FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2166883265> ?p ?o ?g. }

• W2166883265 endingPage "146" @default.
• W2166883265 startingPage "140" @default.
• W2166883265 abstract "To study concentration changes in collagen degradation markers in patients with diffuse and limited cutaneous systemic sclerosis and patients with scleroderma-related diseases.Pyridinoline cross-link compounds were analysed in urine samples using high-performance liquid chromatography. Samples were analysed for pyridinoline (Pyr), deoxypyridinoline (Dpyr) and soft-tissue pyridinoline (stPyr) in patients with diffuse cutaneous systemic sclerosis (dcSSc, n=23) and limited cutaneous systemic sclerosis (lcSSc, n=48) and in patients with scleroderma-related diseases such as primary Raynaud's phenomenon (pRP, n=16) and secondary Raynaud's phenomenon (sRP, n=14). Healthy controls (n=18) and patients with post-menopausal osteoporosis (OP, n=35) were also investigated.Urinary Pyr, Dpyr and stPyr concentrations were significantly higher in patients with Raynaud's phenomenon and systemic sclerosis than in healthy controls. The highest concentrations (two to three times greater than in healthy controls) were found in patients with dcSSc. The stPyr concentration was significantly higher in patients with dcSSc than in those with lcSSc, sRP and pRP. No significant difference in stPyr concentration was found between the healthy controls and the OP group, suggesting that stPyr is derived from soft tissues rather than bone. The extent and severity of skin involvement, measured as a skin score, significantly correlated with the concentrations of stPyr and Pyr, whereas no such correlation was found for Dpyr.Increased urinary concentrations of piridinoline cross-links reflect alterations in collagen turnover in both Raynaud's phenomenon and systemic sclerosis. The close correlation between stPyr concentration and the extent of skin involvement in systemic sclerosis suggests that this parameter may be useful in monitoring ongoing fibrosis in this disease." @default.
• W2166883265 created "2016-06-24" @default.
• W2166883265 creator A5014345828 @default.
• W2166883265 creator A5017892278 @default.
• W2166883265 creator A5035965492 @default.
• W2166883265 creator A5036934250 @default.
• W2166883265 creator A5066306496 @default.
• W2166883265 date "2001-02-01" @default.
• W2166883265 modified "2023-10-18" @default.
• W2166883265 title "Increased urinary pyridinoline cross‐link compounds of collagen in patients with systemic sclerosis and Raynaud's phenomenon" @default.
• W2166883265 cites W138672854 @default.
• W2166883265 cites W1674647355 @default.
• W2166883265 cites W1924707321 @default.
• W2166883265 cites W1973168752 @default.
• W2166883265 cites W1976782444 @default.
• W2166883265 cites W1983660056 @default.
• W2166883265 cites W1983809963 @default.
• W2166883265 cites W2025844408 @default.
• W2166883265 cites W2026531001 @default.
• W2166883265 cites W2028921539 @default.
• W2166883265 cites W2030713054 @default.
• W2166883265 cites W2035804296 @default.
• W2166883265 cites W2063205119 @default.
• W2166883265 cites W2065604832 @default.
• W2166883265 cites W2074439465 @default.
• W2166883265 cites W2075609837 @default.
• W2166883265 cites W2077411288 @default.
• W2166883265 cites W2095163677 @default.
• W2166883265 cites W2156068169 @default.
• W2166883265 cites W2156998448 @default.
• W2166883265 cites W2166946653 @default.
• W2166883265 doi "https://doi.org/10.1093/rheumatology/40.2.140" @default.
• W2166883265 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11257149" @default.
• W2166883265 hasPublicationYear "2001" @default.
• W2166883265 type Work @default.
• W2166883265 sameAs 2166883265 @default.
• W2166883265 citedByCount "13" @default.
• W2166883265 countsByYear W21668832652015 @default.
• W2166883265 countsByYear W21668832652022 @default.
• W2166883265 crossrefType "journal-article" @default.
• W2166883265 hasAuthorship W2166883265A5014345828 @default.
• W2166883265 hasAuthorship W2166883265A5017892278 @default.
• W2166883265 hasAuthorship W2166883265A5035965492 @default.
• W2166883265 hasAuthorship W2166883265A5036934250 @default.
• W2166883265 hasAuthorship W2166883265A5066306496 @default.
• W2166883265 hasBestOaLocation W21668832651 @default.
• W2166883265 hasConcept C126322002 @default.
• W2166883265 hasConcept C131075544 @default.
• W2166883265 hasConcept C142724271 @default.
• W2166883265 hasConcept C160160445 @default.
• W2166883265 hasConcept C180032290 @default.
• W2166883265 hasConcept C181199279 @default.
• W2166883265 hasConcept C185592680 @default.
• W2166883265 hasConcept C198451711 @default.
• W2166883265 hasConcept C2776670291 @default.
• W2166883265 hasConcept C2778588143 @default.
• W2166883265 hasConcept C2778751314 @default.
• W2166883265 hasConcept C2779075594 @default.
• W2166883265 hasConcept C2779134260 @default.
• W2166883265 hasConcept C2779625490 @default.
• W2166883265 hasConcept C2779967694 @default.
• W2166883265 hasConcept C2780026642 @default.
• W2166883265 hasConcept C2780787237 @default.
• W2166883265 hasConcept C2910325231 @default.
• W2166883265 hasConcept C55493867 @default.
• W2166883265 hasConcept C71924100 @default.
• W2166883265 hasConcept C77411442 @default.
• W2166883265 hasConcept C90924648 @default.
• W2166883265 hasConceptScore W2166883265C126322002 @default.
• W2166883265 hasConceptScore W2166883265C131075544 @default.
• W2166883265 hasConceptScore W2166883265C142724271 @default.
• W2166883265 hasConceptScore W2166883265C160160445 @default.
• W2166883265 hasConceptScore W2166883265C180032290 @default.
• W2166883265 hasConceptScore W2166883265C181199279 @default.
• W2166883265 hasConceptScore W2166883265C185592680 @default.
• W2166883265 hasConceptScore W2166883265C198451711 @default.
• W2166883265 hasConceptScore W2166883265C2776670291 @default.
• W2166883265 hasConceptScore W2166883265C2778588143 @default.
• W2166883265 hasConceptScore W2166883265C2778751314 @default.
• W2166883265 hasConceptScore W2166883265C2779075594 @default.
• W2166883265 hasConceptScore W2166883265C2779134260 @default.
• W2166883265 hasConceptScore W2166883265C2779625490 @default.
• W2166883265 hasConceptScore W2166883265C2779967694 @default.
• W2166883265 hasConceptScore W2166883265C2780026642 @default.
• W2166883265 hasConceptScore W2166883265C2780787237 @default.
• W2166883265 hasConceptScore W2166883265C2910325231 @default.
• W2166883265 hasConceptScore W2166883265C55493867 @default.
• W2166883265 hasConceptScore W2166883265C71924100 @default.
• W2166883265 hasConceptScore W2166883265C77411442 @default.
• W2166883265 hasConceptScore W2166883265C90924648 @default.
• W2166883265 hasIssue "2" @default.
• W2166883265 hasLocation W21668832651 @default.
• W2166883265 hasLocation W21668832652 @default.
• W2166883265 hasOpenAccess W2166883265 @default.
• W2166883265 hasPrimaryLocation W21668832651 @default.
• W2166883265 hasRelatedWork W1523913907 @default.
• W2166883265 hasRelatedWork W2008286035 @default.
• W2166883265 hasRelatedWork W2045114382 @default.

• next